SanDisk Corporation: The Technology Is Still Not Economical For Mass Adoption
Seeking Alpha· 2025-06-02 18:31
Sandisk Corporation (NASDAQ: SNDK ) recently reported its fiscal third quarter results , and since I covered its previous company before the spinoff, Western Digital ( WDC ), I thought it would be interesting to see how SNDK hasMSc in Finance. Long-term horizon investor mostly with 5-10 year horizon. I like to keep investing simple. I believe a portfolio should consist of a mix of growth, value, and dividend-paying stocks but usually end up looking for value more than anything. I also sell options from time ...
PayPal: This Top Pick Will Rise From The Ashes
Seeking Alpha· 2025-06-02 18:30
PayPal (NASDAQ: PYPL ) has traded with elevated volatility as fintech stocks appear to be favored by momentum investors on recession fears. The company posted a strong quarter with management essentially indicating that they can continue deliveringJulian is the leader of the investing group Best Of Breed Growth Stocks where he only shares positions in stocks which have a large probability of delivering large alpha relative to the S&P 500. He also combines growth-oriented principles with strict valuation hur ...
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial
GlobeNewswire· 2025-06-02 18:30
Media ReleaseCOPENHAGEN, Denmark; June 2, 2025 New data showed that rinatabart sesutecan (Rina-S®) 100 mg/m2 led to a confirmed objective response rate (ORR) of 50.0 percent, including two complete responses (CR), and median duration of response (mDOR) was not reached after a median follow-up of 7.7 monthsContinued evaluation of single-agent Rina-S 100 mg/m2 in patients with advanced endometrial cancer (EC) is ongoing in the Phase 2 RAINFOL™-01 trial and will be further evaluated in a planned Phase 3 trial ...
Correction: Kvika banki hf.: Transaction in relation to a share buy-back programme
GlobeNewswire· 2025-06-02 18:25
On Monday 2.6.2025 Kvika announced that post week 22 buy-back Kvika held 157,410,410 of own shares which corresponds to 2.902% of issued shares. However, 157,410,410 of own shares corresponds to 3.34% of issued shares. The revised announcement is as follows: In week 22 Kvika banki hf. („Kvika“ or „the bank“) purchased 23,000,000 of its own shares at the purchase price ISK 380,150,000. See further details below: DateTimeNo. of shares purchasedShare price (rate)Purchase price26.5.202510:12:071,500,00015.80023 ...
Disney slashing hundreds of jobs in film, TV as Hollywood facing industry turmoil: report
New York Post· 2025-06-02 18:23
Disney is laying off several hundred employees in film, television and corporate finance, a source familiar with the matter said on Monday.The layoffs affect multiple teams around the world, including film and TV marketing, TV publicity, and casting and development, the source said.Disney and other companies are reshaping their business strategies in response to the migration of cable TV audiences to streaming platforms. Bob Iger’s Disney and other companies are reshaping their business strategies in respon ...
Favorite Casino Stock Traders Should Avoid in June
Schaeffers Investment Research· 2025-06-02 18:23
Casino stock Wynn Resorts Inc (NASDAQ:WYNN) is trading 1.9% lower at $88.83 at last check, starting off June on a sour note. The shares are eyeing their fourth-straight loss, extending a pullback from their May 15 five-month highs, and testing support at the $90 level today. Plus, if past is precedent, WYNN could be due for even more losses. Schaeffer's Senior Quantitative Analyst Rocky White compiled a list of the 25 worst S&P 500 Index (SPX) stocks to own in June, going back a decade, and Wynn Resorts sto ...
Warner Bros' Debt Downgrade Is An 'Ironically Positive' Event: Analyst
Benzinga· 2025-06-02 18:20
Bank of America Securities analyst Jessica Reif Ehrlich maintained a Buy rating on Warner Bros. Discovery WBD with a price forecast of $14 on Monday.Ehrlich argued, in an analyst report, that recent developments, notably an internal reorganization and an S&P debt downgrade (viewed as an “ironically positive” event), have increased WBD’s strategic flexibility.While acknowledging challenges, the analyst expressed continued belief in WBD’s compelling collection of assets and upcoming catalysts.Also Read: Warne ...
Hanover Insurance Stock Near 52-Week High: Time to Buy?
ZACKS· 2025-06-02 18:11
Key Takeaways THG shares closed at $175.98, up 13.8% YTD and near their 52-week high of $176.71 Performance is fueled by Core Commercial, Specialty strength, pricing power, and tech investmentsa Analyst estimates for 2025 earnings rose 2% in 30 days, with projected growth of 8.6% year over year.Shares of The Hanover Insurance Group, Inc. (THG) closed at $175.98 on Friday, near their 52-week high of $176.71, after having gained 13.8% year to date. Shares outperformed the industry, the Finance sector, as we ...
Expected divestment of Roblon’s US subsidiary and upgraded full-year 2024/25 guidance for continuing operations
GlobeNewswire· 2025-06-02 18:11
Attached please find Company Announcement no 6 - 2025 Attachment Company Announcement no 6 - 2025 ...
CSPC PHARMACEUTICAL(1093.HK):LARGE-SCALE BD OUT-LICENSING DEALS LIKELY IN NEAR TERM
格隆汇· 2025-06-02 18:07
机构:招银国际 研究员:Jill WU/Andy WANG Business sequentially recovered in 1Q. CSPC reported total revenue of RMB7.0bn in 1Q25, including RMB718mn from out-licensing (BD) income. Excluding the impact from BD, core revenue reached RMB6.3bn (+1% QoQ), representing 22% of our previous FY25 estimates. Excluding the BD impact, core net profit reached RMB868mn (+58% QoQ), accounting for 27% of our FY25 estimates. Sales of finished drugs (excluding BD income) declined 5% QoQ and decreased 37% YoY, mainly due to a 21% QoQ de ...